Modern possibilities of a supporting therapy and correction of post-inflammatory skin changes in patients with acne
- 作者: Tlish M.M.1, Shavilova M.E.1
-
隶属关系:
- Kuban State Medical University
- 期: 卷 97, 编号 4 (2021)
- 页面: 92-99
- 栏目: ORIGINAL STUDIES
- URL: https://journals.rcsi.science/0042-4609/article/view/117602
- DOI: https://doi.org/10.25208/vdv1241
- ID: 117602
如何引用文章
全文:
详细
Background. Acne has a net detrimental effect on the quality of life of patients, which is due not only to long-term treatment and predominance of dermatosis on the face, but also due to substantial risk of development of enduring post-inflammatory skin changes. The main part of treatment methods for post-acne marks is currently aimed at correction of already formed rash, and not at prevention of its development. In this respect, studies aimed at development of new methods for prevention and treatment of post-inflammatory skin changes in acne are particularly topical.
Aim. To evaluate clinical efficiency and tolerability of Postacnetin gel at prevention and correction of significant post-inflammatory skin changes in patients with severe forms of acne vulgaris.
Methods. 60 patients with severe forms of acne were under observation and were prescribed isotretinoin and topical medications in accordance with the Federal Guidelines of Treatment. Depending on the planned supporting therapy, the patients were divided into main and control groups of 30 people. Patients of the control group used only adapalene cream after the end of the course of systemic treatment with isotretinoin. Patients of the main group were additionally prescribed Postacnetin gel 2 months before reaching the cumulated dose of isotretinoin, and were also recommended to use it within 4 months after termination of isotretinoin therapy alongside with the use of adapalene cream. The effect of Postacnetin gel on post-inflammatory skin changes was assessed over time by counting post-acne elements, mexametry data and results of assessment of cicatrical changes according to the scale of G. Goodmann et al. Tolerability of the therapy was studied by means of monitoring of adverse reactions and calculation of the dermatology life quality index (DLQI).
Results. By the end of application of the systemic medication, persistent erythema developed less often in patients of the main group, and pigmentation and scars were clinically less severe according to the data of the mexametry and the scale of G. Goodman et al. Subsequent dynamic observation of patients of the main group revealed more significant regression of post-inflammatory changes in them. Thus, dark spots were less common in these patients in the 2nd and 4th months in comparison with the control group, and according to mexametry data, they were less severe. They also had lower severity of scars and level of the total index of the quantitative scale of G. Goodman et al. According to the results of monitoring of side effects and DLQI, both treatment regimens were well tolerated.
Conclusion. The use of Postacnetin gel in the complex therapy of patients with severe forms of acne vulgaris is an effective method for prevention and correction of persistent post-inflammatory skin changes and is well tolerated by patients.
作者简介
Marina Tlish
Kuban State Medical University
Email: tlish_mm@mail.ru
ORCID iD: 0000-0001-9323-4604
SPIN 代码: 8452-4062
MD, Dr. Sci. (Med.), Professor
俄罗斯联邦, Sedina str., 4, KrasnodarMarina Shavilova
Kuban State Medical University
编辑信件的主要联系方式.
Email: marina@netzkom.ru
ORCID iD: 0000-0002-5776-6221
SPIN 代码: 3346-6060
俄罗斯联邦, Sedina str., 4, Krasnodar
参考
- Кубанова А.А, Самцов А.В., Аравийская Е.Р. Федеральные клинические рекомендации. Акне. Москва, 2017. [Kubanova AA, Samtsov AV, Aravijskaya ER. Federal clinical guidelines. Acne. Moscow, 2017. https://www.cnikvi.ru/docs/clinic_recs/klinicheskie-rekomendatsii-2017] (In Russ.)
- Heng AHS, Chew FT. Systematic review of the epidemiology of acne vulgaris. Sci Rep. 2020;10(1):5754. doi: 10.1038/s41598-020-62715-3
- Layton A, Thiboutot D, Tan J. Reviewing the global burden of acne: how could we improve care to reduce the burden? British Journal of Dermatology. 2021;184(2):219–225. doi: 10.1111/bjd.19477
- Круглова Л.С., Грязева Н.В., Талыбова А.М. Симптомокомплекс постакне: методы профилактики и терапии. Клиническая дерматология и венерология. 2020;19(5):622–629. [Kruglova LS, Gryazeva NV, Talybova AM. Post-acne symptom complex: methods of prevention and therapy. Klinicheskaya dermatologiya i venerologiya. 2020;19(5):622–629 (In Russ.)]
- Connolly D, Vu HL, Mariwalla K, Saedi N. Acne scarring-pathogenesis, evaluation, and treatment options. The Journal of clinical and aesthetic dermatology. 2017;10(9):12–23.
- Rodrigues M, Ayala-Cortes AS. Post-inflammatory Hyperpigmen-tation. In: Kumarasinghe P. (eds). Pigmentary Skin Disorders. Updates in Clinical Dermatology. Springer, 2018:197–208.
- Abad-Casintahan F, Chow SK, Goh CL, Kubba R, Hayashi N, Noppakun N, et al. Asian Acne Board. Frequency and characteristics of acne-related post-inflammatory hyperpigmentation. J Dermatol. 2016;43(7):826–828. doi: 10.1111/1346-8138.13263
- Круглова Л.С., Колчева П.А., Корчажкина Н.Б. Обзор современных методов коррекции рубцов постакне. Вестник новых медицинских технологий. 2018;4:155–163 [Kruglova LS, Kolcheva PA, Korchazhkina NB. Review of modern methods of correction of post-acne scars. Vestnik novyh medicinskih tekhnologij. 2018;4:155–163 (In Russ.)]
- Saint-Jean M, Khammari A, Jasson F, Nguyen JM, Dréno B. Different cutaneous innate immunity profiles in acne patients with and without atrophic scars. Eur J Dermatol. 2016;26(1):68–74. doi: 10.1684/ejd.2015.2713
- Kravvas G, Al-Niaimi F. A systematic review of treatments for acne scarring. Part 1: Non-energy-based techniques. Scars, Burns & Healing, 2017;3:1–17. doi: 10.1177/2059513117695312
- Мантурова Н.Е., Талыбова А.М., Круглова Л.С., Стенько А.Г. Профилактика и лечение атрофических рубцов постакне. Клиническая дерматология и венерология. 2018;17(5):85–100 [Manturova NE, Talybova AM, Kruglova LS, Stenko AG. Prevention and treatment of atrophic post-acne scars. Klinicheskaya dermatologiya i venerologiya. 2018;17(5):85–100 (In Russ.)]
- Тлиш М.М., Шавилова М.Е. Изотретиноин в терапии акне. Вестник дерматологии и венерологии. 2017;4:90–6 [Tlish MM, Sрavilova ME. Isotrethinoine in acne therapy. Vestnik dermatologii i venerologii. 2017;4:90–6 (In Russ.)]. doi: 10.25208/0042-4609-2017-93-4-90-96
- Nast A, Dréno B, Bettoli V, Bukvic Mokos Z, Degitz K, Dressler C, et al. European evidence-based (S3) guideline for the treatment of acne — update 2016 — short version. J Eur Acad Dermatol Venereol. 2016;30(8):1261–1268. doi: 10.1111/jdv.13776
- Raake W, Hoppensteadt D, Schultz C, Neville B, Fareed J. Down regulation of inflammatory markers after treatment with topically administered mucopolysaccharide polysulfate. Blood. 2004;104(11):4073.
- Zhang Q, Zhou Y, Chen L, Xu Y. [Therapeutic effect of mucopolysaccharide polysulfate cream in prevention of postoperative scars]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2018;43(3):293–300. Chinese. doi: 10.11817/j.issn.1672-7347.2018.03.010
- Wanitphakdeedecha R, Eimpunth S, Manuskiatti W. The effects of mucopolysaccharide polysulphate on hydration and elasticity of human skin. Dermatology Research and Practice. 2011:1–5. doi: 10.1155/2011/807906.
- Sidgwick GP, McGeorge D, Bayat A. A comprehensive evidence-based review on the role of topicals and dressings in the management of skin scarring. Arch Dermatol Res. 2015;307(6):461–477. doi: 10.1007/s00403-015-1572-0
- Araujo LU, Grabe-Guimaraes A, Mosqueira VC, Carneiro CM, Silva-Barcellos NM. Profile of wound healing process induced by allantoin. Acta Cir Bras. 2010;25(5):460–466.
- Forbat E, Al-Niaimi F, Ali FR. Use of nicotinamide in dermatology. Clinical and Experimental Dermatology. 2017;42(2):137–144.
- Goodman G. Treatment of acne scarring. Int J Dermatol. 2011;50:1179–1194. doi: 10.1111/j.1365-4632.2011.05029.x
补充文件
